FFA
TRIB

Farther Finance Advisors’s Trinity Biotech TRIB Stock Holding History

Farther Finance Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$778 Hold
67
– – ﹤0.01% 5434
2026
Q1 		$1.2K Hold
67
– – ﹤0.01% 5056
2025
Q4 		$1.58K Hold
67
– – ﹤0.01% 4777
2025
Q3 		$2.08K Hold
67
– – ﹤0.01% 4128
2025
Q2 		$1.3K Hold
67
– – ﹤0.01% 3836
2025
Q1 		$1.14K Buy
+67
New +$1.59K ﹤0.01% 3569

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Farther Finance Advisors's TRIB Position: Q2 2026 in Review

Farther Finance Advisors held its Trinity Biotech (TRIB) position steady in Q2 2026 at 67 shares worth $778. The position accounts for ﹤0.01% of the portfolio, ranked #5434.

Farther Finance Advisors first reported a position in TRIB in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.08K in Q3 2025. 19 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.

  • Farther Finance Advisors held 67 shares of Trinity Biotech worth $778 as of Q2 2026.
  • Farther Finance Advisors left its Trinity Biotech share count unchanged in Q2 2026.
  • Trinity Biotech made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5434 holding.
  • Farther Finance Advisors first reported a position in Trinity Biotech in Q1 2025 and has held it in 6 quarters since.
  • Farther Finance Advisors's Trinity Biotech position peaked at $2.08K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.